RACI Congress 2026

Preclinical CRO

July 5-10, 2026
Perth Convention & Exhibition Centre, Perth, Western Australia
Medicilon Booth #9

ASMS 2026

Medicilon Events

May 31 – June 4, 2026
San Diego Convention Center

KSNS 2026

Preclinical CRO

May 29, 2026
Suwon Convention Center

AOC Development: Conjugation Site Selection, DAR Control & In Vitro Testing | Full Webinar

Medicilion Congratulates MediLink Therapeutics on Licensing B7H3 ADC to Roche

Oligonucleotide therapeutics hold great promise, but extrahepatic delivery remains a challenge. Antibody–oligonucleotide conjugates (AOCs) are emerging as a powerful solution – provided you can master conjugation chemistry, DAR control, analytical characterization, and functional assessment. https://www.youtube.com/watch?v=CNr9ZsU2qrk In this recorded webinar, our experts from Medicilon cover: How conjugation chemistry impacts AOC consistency and developability Why DAR control […]

Search Medicilon

Preclinical CRO

Medicilon Congratulates : MindRank AI-Developed Oral GLP-1 MDR-001 Secures Up to RMB 1.75 Billion Exclusive Commercialization Deal with Sunshine Mandi

Preclinical CRO

A Note of Appreciation, A Mark of Recognition | Medicilon Supports Partner Tasly in Obtaining Clinical Trial Approval for TSL2402 Tablets

BIOJAPAN 2026

Contact Medicilon

Name(Required)
Address(Required)